請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89060
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘令妍 | zh_TW |
dc.contributor.advisor | Ling-Yen Pan | en |
dc.contributor.author | 曾麒豪 | zh_TW |
dc.contributor.author | Chi-Hao Tseng | en |
dc.date.accessioned | 2023-08-16T16:57:49Z | - |
dc.date.available | 2023-11-09 | - |
dc.date.copyright | 2023-08-16 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-07 | - |
dc.identifier.citation | 衛生福利部中央健康保險署 (2023), ”全民健康保險藥物給付項目及支付標準-第6編第83條之藥品給付規定第14節眼科製劑Ophthalmnic preparations\14.9.2.新生血管抑制劑” https://www.nhi.gov.tw/BBS_Detail.aspx?n=73CEDFC921268679&sms=D6D5367550F18590&s=0FBC91870C63CAF5
夏昀, & 何子昌. (2021). 白內障治療之醫病共享決策. 台灣醫學, 25(2), 226-230. Becker, L., & Jaakkola, E. (2020). Customer experience: fundamental premises and implications for research. Journal of the Academy of Marketing Science, 48, 630-648. Beleffi, E., Mosconi, P., & Sheridan, S. (2020). The Patient Journey. In L. Donaldson (Eds.) et. al., Textbook of Patient Safety and Clinical Risk Management. (pp. 117–127). Springer. Bhagat, N., Zarbin, M. A., & Mukkamala, L. Diabetic Macular Edema. https://eyewiki.aao.org/Diabetic_Macular_Edema Boyer, D. S., Yoon, Y. H., Belfort Jr, R., Bandello, F., Maturi, R. K., Augustin, A. J., ... & Ozurdex MEAD Study Group. (2014). Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology, 121(10), 1904-1914. Brown, D. M., Emanuelli, A., Bandello, F., Barranco, J. J. E., Figueira, J., Souied, E., ... & Garweg, J. G. (2022). KESTREL and KITE: 52-week results from two phase III pivotal trials of brolucizumab for diabetic macular edema. American Journal of Ophthalmology, 238, 157-172. Brown, D. M., Schmidt-Erfurth, U., Do, D. V., Holz, F. G., Boyer, D. S., Midena, E., ... & Korobelnik, J. F. (2015). Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology, 122(10), 2044-2052. Brownlee M. (2005). The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54(6), 1615–1625. Chhablani, J., Wong, K., Tan, G. S., Sudhalkar, A., Laude, A., Cheung, C. M. G., ... & Koh, A. (2020). Diabetic macular edema management in Asian population: expert panel consensus guidelines. The Asia-Pacific Journal of Ophthalmology, 9(5), 426-434. Early Treatment Diabetic Retinopathy Study Research Group. (1985). Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol, 103, 1796-1806. Gualandi, R., Masella, C., Viglione, D., & Tartaglini, D. (2019). Exploring the hospital patient journey: What does the patient experience?. PloS One, 14(12), e0224899 Kuehnl, C., Jozic, D., & Homburg, C. (2019). Effective customer journey design: consumers’ conception, measurement, and consequences. Journal of the Academy of Marketing Science, 47, 551-568. Legard, R., Keegan, J., & Ward, K. (2003). In-depth interviews. Qualitative research practice: A Guide for Social Science Students and Researchers, 6(1), 138-169. Lemon, K. N., & Verhoef, P. C. (2016). Understanding customer experience throughout the customer journey. Journal of Marketing, 80(6), 69-96 Lin, J. C., Shau, W. Y., & Lai, M. S. (2014). Sex-and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmology, 132(8), 922-928. Midena, E., Polo, C., Frizziero, L., Marini, M. G., Lattanzio, R., Vadalà, M., ... & Varano, M. (2022). The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience. International Journal of Environmental Research and Public Health, 19(15), 9367. Nguyen, Q. D., Brown, D. M., Marcus, D. M., Boyer, D. S., Patel, S., Feiner, L., ... & Rise and Ride Research Group. (2012). Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology, 119(4), 789-801. Rosenbaum, M. S., Otalora, M. L., & Ramírez, G. C. (2017). How to create a realistic customer journey map. Business Horizons, 60(1), 143-150. Siebert, A., Gopaldas, A., Lindridge, A., & Simões, C. (2020). Customer experience journeys: Loyalty loops versus involvement spirals. Journal of Marketing, 84(4), 45-66. Schau, H. J., & Akaka, M. A. (2021). From customer journeys to consumption journeys: a consumer culture approach to investigating value creation in practice-embedded consumption. AMS Review, 11, 9-22. Sheu, S. J., Cheng, C. K., Kuo, H. K., Tsai, C. Y., Lin, T. C., Tan, J., ... & Chen, S. J. (2018). Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review. Clinical Ophthalmology, 2189-2198. Temkin, B. D. (2010). Mapping the customer journey. Forrester Research, 3, 20. Teo, Z. L., Tham, Y. C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., ... & Cheng, C. Y. (2021). Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology, 128(11), 1580-1591. Ting, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016). Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clinical & Experimental Ophthalmology, 44(4), 260-277. Trebble, T. M., Hansi, N., Hydes, T., Smith, M. A., & Baker, M. (2010). Process mapping the patient journey: an introduction. BMJ (Clinical Research ed.), 341, c4078. Tripathy, K., Raj Sharma, Y., Chawla, R., Gogia, V., Kumar Singh, S., Venkatesh, P., & Vohra, R. (2015). Recent advances in management of diabetic macular edema. Current Diabetes Reviews, 11(2), 79-97. Wickham R. J. (2019). Secondary Analysis Research. Journal of the Advanced Practitioner in Oncology, 10(4), 395–400. Witell, L., Kowalkowski, C., Perks, H., Raddats, C., Schwabe, M., Benedettini, O., & Burton, J. (2020). Characterizing customer experience management in business markets. Journal of Business Research, 116, 420-430. Wykoff, C. C., Abreu, F., Adamis, A. P., Basu, K., Eichenbaum, D. A., Haskova, Z., ... & Hirakata, A. (2022). Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. The Lancet, 399(10326), 741-755. Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... & Meta-Analysis for Eye Disease (META-EYE) Study Group. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556-564. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89060 | - |
dc.description.abstract | 糖尿病作為全球範疇內的重要健康議題,對全球醫療系統和藥物行銷策略具有深遠影響。糖尿病所衍生的併發症,不僅使得疾病管理日益複雜,並且對患者的生活質素帶來顯著影響。在此之中,糖尿病視網膜病變及糖尿病黃斑部水腫成為主要的關注重點。在藥品行銷策略的制定過程中,必須考量到這些疾病的獨特性,以及患者在疾病治療旅程中所面臨的需求與痛點。
本研究著眼於糖尿病黃斑部水腫的治療探討,並透過病患旅程地圖的運用,以設計出符合患者需求與醫療標準的服務,旨在提升患者的治療效益以及生活品質。糖尿病黃斑部水腫作為一種普遍的視網膜疾病,其治療過程十分複雜,並需長期的追蹤和管理。因此,本研究主要集中在糖尿病黃斑部水腫的治療過程中,包括患者的需求與期待、疾病認知以及他們所承受的心理壓力等。 本研究運用質性研究方法,透過深度訪談和焦點團體討論,收集患者和醫護人員的意見和建議。研究結果指出,患者需要的是個人化和患者為中心的護理,並需要更多的心理與社會支持。此外,患者對疾病的認知和理解程度也影響他們的治療效果和生活品質。因此,本研究提出了一種病患旅程地圖的應用模型,以協助醫護人員更深入了解患者的需求與期待,並提供更個人化和以患者為中心的護理。本研究也提出一些具體建議,以協助醫護人員進行更有效的溝通和協調,以提升患者的治療效果和生活品質。 研究結果強調,患者對疾病的認知和理解程度是影響治療效果和生活品質的重要因素。因此,本研究提出了一些具體的建議,以協助醫護人員更有效地向患者進行衛教和溝通。例如,醫護人員可以用簡單易懂的語言和圖像,向患者解釋疾病的原因、治療方法和預後等資訊。此外,醫護人員還可以透過多種途徑,如手機應用程式、網站、社交媒體等,向患者提供更便捷和個性化的衛教和支援。 研究結果也指出,患者需要更多的心理和社會支持,以應對治療過程中的壓力和困難。因此,本研究提出了一些具體的建議,以協助醫護人員更有效地提供心理和社會支持。例如,醫護人員可以透過心理輔導、社會工作等方式,幫助患者應對治療過程中的壓力和困難。此外,醫護人員還可以透過建立患者支援小組、提供社區資源等方式,為患者提供更全面和個人化的支援。 | zh_TW |
dc.description.abstract | Diabetes, as a global health concern, profoundly impacts the global healthcare system and pharmaceutical marketing strategies. Complications arising from diabetes not only complicate disease management but significantly affect patients’ quality of life. In this regard, diabetic retinopathy and diabetic macular edema have emerged as the primary points of concern. The unique characteristics of these diseases, along with the needs and pain points patients encounter throughout their treatment journey, must be considered in the formulation of pharmaceutical marketing strategies.
This study focuses on the treatment of diabetic macular edema and applies the concept of a patient journey map to design services that meet patient needs and medical standards. This aims to enhance the treatment outcomes and quality of life for patients. Diabetic macular edema, as a common retinal disease, involves a complex treatment process that requires long-term follow-up and management. Hence, this research mainly concentrates on various aspects within the treatment journey of diabetic macular edema, including patients' needs and expectations, disease awareness, and the psychological stress they endure. Through qualitative research methods, in-depth interviews, and focus group discussions, this study collects opinions and suggestions from patients and healthcare providers. The findings suggest that patients require personalized, patient-centered care and greater psychological and social support. Moreover, the degree of patients' disease understanding impacts their treatment outcomes and quality of life. Consequently, this study proposes an application model of a patient journey map to assist healthcare providers in better understanding patients' needs and expectations and to provide more personalized and patient-centered care. Furthermore, this research offers specific recommendations to help healthcare providers enhance their communication and coordination, thereby improving patient treatment outcomes and quality of life. The study emphasizes that patients' understanding of the disease is a critical factor affecting treatment outcomes and quality of life. Thus, specific recommendations are proposed to help healthcare providers educate and communicate more effectively with patients. For example, healthcare providers can use simple language and images to explain the causes of the disease, treatment methods, and prognosis. In addition, through various channels such as mobile apps, websites, and social media, healthcare providers can offer more convenient and personalized education and support to patients. The study also indicates that patients require more psychological and social support to cope with stress and difficulties during the treatment process. Accordingly, this study suggests specific recommendations to aid healthcare providers in providing better psychological and social support. For instance, healthcare providers can use counseling and social work to help patients cope with stress and difficulties during the treatment process. Additionally, by establishing patient support groups and providing community resources, healthcare providers can offer more comprehensive and personalized support. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-08-16T16:57:49Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-08-16T16:57:49Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | 口試委員審定書 I
誌謝 II 目 錄 III 表目錄 V 圖目錄 VI ABSTRACT VIII 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究目的與問題 4 第三節 研究流程 11 第二章 文獻探討 12 第一節 糖尿病黃斑部水腫之相關研究 12 第二節 從客戶旅程地圖到病患旅程地圖 19 第三章 研究方法 27 第一節 質性研究方法 27 第二節 研究範疇與研究對象 29 第三節 訪談大綱 32 第四章 研究結果 34 第一節 繪製病患旅程地圖與定義關鍵角色 34 第二節 病患旅程地圖各階段關鍵重點與問題點 39 第三節 關鍵角色之共同期待 61 第四節 小結 65 第五章 結論與建議 67 第一節 主要研究發現 67 第二節 學術貢獻與實務意涵 68 第三節 研究限制與未來研究方向 69 參考文獻 70 中文文獻 70 英文文獻 71 | - |
dc.language.iso | zh_TW | - |
dc.title | 糖尿病黃斑部水腫之病患旅程與關鍵角色分析 | zh_TW |
dc.title | Analysis of the Patient Journey and Key Roles in Diabetic Macular Edema | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 黃恆獎;胡凱焜 | zh_TW |
dc.contributor.oralexamcommittee | Heng-Chiang Huang;Kae-Kuen Hu | en |
dc.subject.keyword | 病患旅程地圖,關鍵角色,糖尿病黃斑部水腫,行銷策略,質性研究方法, | zh_TW |
dc.subject.keyword | Patient Journey Map,Key Stakeholders,Diabetic Macular Edema,Marketing Strategies,Qualitative Research Method, | en |
dc.relation.page | 73 | - |
dc.identifier.doi | 10.6342/NTU202303488 | - |
dc.rights.note | 同意授權(全球公開) | - |
dc.date.accepted | 2023-08-09 | - |
dc.contributor.author-college | 進修推廣學院 | - |
dc.contributor.author-dept | 生物科技管理碩士在職學位學程 | - |
顯示於系所單位: | 生物科技管理碩士在職學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-2.pdf | 2.04 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。